Related by context. Frequent words. (Click for all words.) 58 Phase Ib clinical 58 Phase 1a 58 phase IIa 57 phase IIb 56 Phase II 55 Phase 55 TG# [001] 55 Phase 1b 54 Phase III 54 IND submission 53 Phase 2b study 53 Phase 2b trial 53 ASA# 53 Phase 2a trial 53 confirmatory Phase III 53 Phase Ib 52 unblinding 52 registrational trial 52 BCX# 52 dose escalation trial 52 BrachySil 52 multiple ascending dose 51 placebo controlled clinical 51 Phase 2b clinical 51 Azedra 51 prefeasibility 51 BLA submission 51 phase 2a 51 Prefeasibility Study 51 Pivotal Phase 51 Allovectin 7 R 50 Phase 1b clinical 50 Phase 2a clinical 50 IMC A# 50 Phase IIa clinical trials 50 registrational 50 pertuzumab 50 AP# [003] 50 Phase IIb trial 50 confirmatory Phase 3 50 Cloretazine R VNP#M 50 Phases II 50 GV# [001] 50 Phase 2a 50 Pivotal Trial 50 PA# [002] 50 ozarelix 50 OXi# 49 Phase Ia 49 eltrombopag 49 flowsheet 49 Ofatumumab 49 Phenoptin 49 axitinib 49 CR# vcMMAE 49 IMGN# 49 Sym# 49 JORC compliant resource 49 Phase III Clinical Trial 49 randomized controlled clinical 49 nab paclitaxel 49 MOZOBIL 49 tanespimycin 48 metastatic hormone refractory 48 Phase IIb 48 dose escalation 48 randomized Phase III 48 IIa clinical trial 48 PF # [001] 48 IP geophysical 48 RG# [001] 48 tesmilifene 48 Pivotal Phase III 48 pharmacodynamic effects 48 Bankable Feasibility Study 48 methylnaltrexone 48 deforolimus 48 PRECiSE 48 Phase IIa trial 48 sapacitabine 48 preclinical toxicology 48 Clinical Trial Results 48 relapsed refractory multiple myeloma 48 maribavir 48 alvimopan 48 Ostarine 48 Phase IIa clinical 48 double blinded placebo 48 soil geochemical sampling 48 ADVENT 48 Pre Feasibility 47 IND enabling 47 NGX# 47 HuMax CD# 47 IIb 47 auger drill 47 velaglucerase alfa 47 PROMACTA 47 BAY #-# 47 clinical trial 47 HGS ETR1